Notes to Editors
About IBA
IBA (Ion Beam Applications S.A.) is a cancer diagnostics and treatment equipment company, and the worldwide technology leader in the field of proton therapy, the most advanced form of radiotherapy available today.
Ad Statistics
Times Displayed: 49670
Times Visited: 1409 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
The Company's primary expertise lies in the development of next generation proton therapy technologies that provide oncology care providers with premium quality services and equipment. IBA's proton therapy solutions are scalable and adaptable, offering universal full scale proton therapy centers as well as next generation compact, single room solutions. IBA also focuses on the development and supply of dosimetry solutions for Quality Assurance of medical equipment and increased patient safety as well as particle accelerators for medical and industrial applications.
Headquartered in Belgium and employing more than 1,000 people worldwide, IBA currently has installed systems across Europe and the US and is expanding into emerging markets. The Company is focused on building sustainable global growth for investors, providing solutions in the fight against cancer.
IBA is listed on the pan-European stock exchange EURONEXT. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB) and more information can be found at: www.iba-worldwide.com
About the University of Iowa
With just over 30,000 students, the University of Iowa is one of the nation's top public research universities, a member of the Big Ten conference since 1899, and an Association of American Universities member since 1909. Iowa is known around the world for its balanced commitment to the arts, sciences, and humanities. It's home to one of the nation's largest academic medical centers, the pioneering Iowa Writers' Workshop, and hundreds of options for affordable, accessible education. More at http://www.uiowa.edu/.
For further information please contact:
IBA
Olivier de Sadeleer
Marketing Manager Proton Therapy
t. +32 10 47 58 90
e. communication@iba-group.com
Thomas Ralet
Vice-President Corporate Communication
t. +32 10 475 890
e. communication@iba-group.com
University of Iowa
Dan Hyer
Proton Therapy Technical Director
t. +1 319 356 2441
e. daniel-hyer@uiowa.edu
Zev Sunleaf
Executive Director
University of Iowa Research Foundation
t. 1 319 335 4155
e. zev-sunleaf@uiowa.edu
Back to HCB News
